Gastrointestinal Endoscopy Devices – Market Insights – Europe

The European GI endoscopy device market is showing strong recovery from the short-term impacts of the COVID-19 pandemic and will continue to expand at a modest pace through 2032. Procedure volume growth throughout the region will be supported by treatment and screening guidelines as well as increasing adoption of underpenetrated endoscopic procedures, such as Barrett’s esophagus ablations. Furthermore, the growing integration of AI in GI videoscope systems is poised to foster overall market growth. However, despite these positive trends, the pace of overall market growth will be limited by increased hospital consolidation, which will limit capital equipment sales volumes to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Europe from 2019 through 2032.

The European GI endoscopy device market has shown strong recovery from the negative impact of the COVID-19 pandemic.

To what extent did the COVID-19 pandemic impact the European market?

Which GI endoscopy procedures were affected the most by pandemic-related deferrals, and how quickly have procedure volumes been recovering?

AI and CAD are expanding the possibilities for innovation within the GI device market in Europe.

How does the integration of AI and CAD into endoscopy affect the market for GI endoscopy devices?

What AI-enabled videoscope systems are currently available in the European markets?

Which companies are planning to provide AI capabilities in the upcoming years?

The implementation of screening guidelines in Europe is expected to affect certain markets for GI endoscopy devices.

What recent guidelines have been implemented, and how will they affect the number of procedures performed?

Which device markets will be most impacted by updated screening recommendations and screening innovations?

Videoscope sales will be negatively affected by concerns surrounding the contamination of reprocessed scopes.

How have concerns surrounding the contamination of reprocessed videoscopes impacted procedure volumes and sales in Europe?

What are the latest innovations and guidelines that could mitigate the risk of contamination?

Which competitors are best positioned to improve their competitive standing by addressing these issues?

Markets with innovative devices will experience faster growth.

What will drive the adoption of premium-priced innovative devices, such as capsule endoscopes and Barrett’s esophagus ablation devices?

Are any innovative products expected in relatively more mature market segments?

Table of contents